A novel immune prognostic index for stratification of high-risk patients with early breast cancer

The prognostic value of current multigene assays for breast cancer is limited to hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer. Despite the prognostic significance of immune response-related genes in breast cancer, immune gene signatures have not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hannah, Kwon, Mi Jeong, Koo, Beom-Mo, Park, Hee Geon, Han, Jinil, Shin, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794340/
https://www.ncbi.nlm.nih.gov/pubmed/33420250
http://dx.doi.org/10.1038/s41598-020-80274-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794340/
https://www.ncbi.nlm.nih.gov/pubmed/33420250
http://dx.doi.org/10.1038/s41598-020-80274-5

Ejemplares similares